This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Urology news

 

The role of the endocrine system in BPH development

20.01.2017

A new review article published in Andrology summarises the influence of endocrine factors and inflammation in the pathogenesis of benign prostatic hyperplasisa

Read more »

Poor physical health after BPH surgery

20.01.2017

A study of Health-Related Quality of Life (HRQoL), sexual function and psychological well-being found that physical health of BPH patients after prostatic surgery was poor

Read more »

Laser treatment for benign prostatic hyperplasia

20.01.2017

Laser treatment for BPH rivals the gold-standard TURP with fewer complications. This review examines the most commonly used lasers in BPH surgery

Read more »

Resistive index of prostatic blood flow in diagnosis of BPH

20.01.2017

A prospective study in Korea shows the clinical significance of the resistive index of prostatic blood flow for non-invasive diagnosis of BPH with LUTS

Read more »

Androgen receptor expression in benign and malignant epithelium

20.01.2017

Staining intensity for the androgen receptor was more intense in cases of prostate cancer  compared to benign prostatic hyperplasia

Read more »

The relationship between metabolic syndrome, BPH and LUTS

20.01.2017

A new study published in Urology journal has identified that metabolic syndrome is significantly associated with predictors of BPH and the severity of LUTS

Read more »

UroLift in the management of BPH

20.01.2017

A review of the UroLift system in the management of benign prostatic hyperplasia, considering the technique, advantages, limitations and concerns.

Read more »

Updated guidelines for treatment and management of BPH

20.01.2017

Updated guidelines for the treatment and management of patients with benign prostatic hyperplasia recommended by researchers from Toronto, Canada.  

Read more »

Prostatic urethral angle and response to α-blockers

20.01.2017

Research shows that a lower prostatic urethral angle (<33.5°) in patients with LUTS could predict improved response to α-blockers for treatment of nocturia.

Read more »

MRI classification of BPH may improve treatment options

20.01.2017

Researchers from Chicago suggest that superior contrast of MRI appears better than ultrasound for classification of types of benign prostatic hyperplasia.

Read more »

Economic analysis of PSA screening and treatment strategies

20.01.2017

Researchers from Seattle suggest strategies to extend PSA screening interval or higher PSA biopsy thresholds could preserve therapeutic benefit and cost.

Read more »